Why Rigel (RIGL) Could Beat Earnings Estimates Again

Core Insights - Rigel Pharmaceuticals has a strong track record of beating earnings estimates, with an average surprise of 197.73% over the last two quarters [1] - The company reported earnings of $0.14 per share for the most recent quarter, exceeding expectations by 350.00%, while the previous quarter's earnings were $0.80 per share against an estimate of $0.55, resulting in a surprise of 45.45% [2] Earnings Estimates and Predictions - Recent estimates for Rigel have been increasing, with a positive Earnings ESP of +23.86%, indicating bullish sentiment among analysts regarding the company's earnings prospects [5][8] - The combination of a positive Earnings ESP and a Zacks Rank of 2 (Buy) suggests a high likelihood of another earnings beat in the upcoming report scheduled for August 5, 2025 [8] Earnings ESP and Market Behavior - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have historically produced positive surprises nearly 70% of the time, indicating a strong correlation between these metrics and earnings performance [6] - The Earnings ESP metric compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may provide more accurate predictions [7]